Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Cyclophosphamide, Cellular Adoptive Immunotherapy, and Aldesleukin in Treating Patients With Metastatic Melanoma
This study is ongoing, but not recruiting participants.
Study NCT00438984.   Last updated on December 13, 2008.
Information provided by National Cancer Institute (NCI)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00438984
Locations
United States, Washington
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States, 98109-1024
Seattle Cancer Care Alliance
Seattle, Washington, United States, 98109-1023
Sponsors and Collaborators
Fred Hutchinson Cancer Research Center
National Cancer Institute (NCI)
Investigators
Principal Investigator: Cassian Yee, MD Fred Hutchinson Cancer Research Center




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services